Welcome to our dedicated page for Unilever SEC filings (Ticker: UL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Unilever plc SEC filings document the disclosure record of a foreign private issuer with ordinary shares and American depositary shares tied to a global consumer goods business. Form 6-K reports include voting-rights and capital updates, share buyback announcements, Annual General Meeting notices, proxy materials and public disclosures of transactions by persons discharging managerial responsibilities.
The filing record also incorporates operating and financial results, material-event reports, registration-statement references, risk disclosures and governance matters. These documents describe Unilever's capital structure, shareholder voting mechanics, board authorities, equity compensation registrations and recurring regulatory communications under U.S. and U.K. disclosure regimes.
Unilever PLC reported that the UK Financial Conduct Authority approved a Supplement dated 24 October 2025 to the U.S.$25,000,000,000 Debt Issuance Programme of Unilever Finance Netherlands B.V., Unilever Capital Corporation and Unilever PLC (as issuers), with Unilever PLC and Unilever United States, Inc. as guarantors.
The Supplement is to be read with the Information Memorandum dated 16 May 2025, as previously supplemented on 31 July 2025. Links are provided to the Supplement and Unilever’s Q3 2025 full announcement, and the materials will be available via the UK National Storage Mechanism. This notice updates programme documentation and does not announce a specific securities issuance.
Unilever PLC submitted a Form 6-K as a foreign private issuer. The report is being formally incorporated by reference into existing shelf and employee share plan registration statements on Form F-3 and Form S-8. The filing mainly transmits an exhibit titled “Update on Demerger and Share Consolidation Timetable,” dated 21 October 2025, which is intended to inform investors about timing aspects of Unilever’s planned demerger and related share consolidation.
Unilever PLC has announced the appointment of Belén Garijo López as an independent Non-Executive Director, effective 13 May 2026. Ms. Garijo currently serves as Chair of the Executive Board and CEO of Merck Group until the end of April 2026, sits on the board of BBVA, and was a Non-Executive Director at L'Oreal from 2014 to 2024. The company highlights her global commercial experience across FMCG and healthcare and her record on diversity and transformation. The announcement complies with UK Listing Rule disclosures and provides no additional material details.
Unilever PLC provided an update on its issued share capital and voting rights as at 30 September 2025. The company reported 2,524,997,338 ordinary shares in issue, of which 71,366,436 were held as treasury shares and 1,745,646 were held by Unilever group companies with non-exercisable voting rights. After excluding treasury and non-exercisable group-held shares, there were 2,451,885,256 shares carrying voting rights. The filing states this figure may be used as the denominator for shareholders to determine notification thresholds under the UK Financial Conduct Authority rules.
Unilever PLC filed a corrective Form 6-K restating a prior "Director/PDMR Shareholding" announcement from 19 September 2025. The correction updates the aggregated number of EUR-denominated shares reported for director Peter Ter Kulve; the company states this is the only change and all other details from the 19 September 2025 announcement remain unchanged. The restated notification is presented in the filing and the document is signed by the Chief Legal Officer and Group Secretary.
Unilever PLC filed a Form 6-K reporting a series of routine share transactions by senior leaders who chose to reinvest cash dividends into Unilever PLC ordinary 3 1/9 pence shares. On 17 September 2025, multiple persons discharging managerial responsibilities, including the Chief Financial Officer and several members of the Unilever Leadership Executive, acquired small numbers of shares through dividend reinvestment agreements that were entered into during an open period. The reinvestments covered both GBP and EUR lines, with example prices of £45.4324 and €52.4898 per share, and trades were executed on the London Stock Exchange and the Amsterdam Stock Exchange. These disclosures reflect ongoing alignment of senior executives with the company’s equity through automatic dividend reinvestment rather than open-market sales.